Human Tissue Act 1983

The Act casts a wide net. Living donors (adults and children) and their parents or guardians are directly affected by the consent and certificate requirements in Part 2 and Part 3. Next of kin of deceased persons occupy a central decision-making role; the statutory hierarchy in s 4(1) determines who is the “senior available next of kin”, with special rules for children (including those in State care) that can elevate the principal care officer under the Children and Young Persons (Care and Protection) Act 1998.

Designated officers and designated specialists appointed by hospital governing bodies or forensic institutions (s 5) are the statutory gatekeepers who must make “such inquiries as are reasonable in the circumstances” before issuing authorities (ss 23, 28, 31A). Medical practitioners who remove tissue, certify capacity or brain death, or perform transplants face personal criminal liability if they act without authority or ignore revocation (ss 15–17, 26, 36). Non-medical technicians may now remove certain tissues (corneas, skin, cardiovascular and musculoskeletal tissue) if appointed in writing by the Health Secretary (s 27(1A)).

Blood suppliers, exempt suppliers and their employees are regulated under Parts 3 and 3A. The Australian Red Cross Society, hospital governing bodies and bodies declared by regulation enjoy exempt-supplier status; others risk 100-penalty-unit fines for carrying on an unauthorised supply business (s 21). Approved health providers (private facilities, accredited pathology laboratories and prescribed classes) must reimburse the State for blood-supply costs (s 37A).

Coroners exercise overriding veto powers wherever an inquest is or may be held (ss 25, 30, 31B). Inspectors appointed by the Health Secretary (s 33A) possess entry, seizure and questioning powers that can be exercised against any premises (including vehicles) where tissue or blood products are kept. Corporate directors and managers are personally liable for corporate breaches of the supply prohibitions (s 21B).

Finally, the Health Secretary holds multiple functions: approving designated specialists (s 5(2)), issuing guidelines (s 27A), recovering blood-supply costs (s 37A), appointing inspectors and technicians, and making regulations. Patients, research institutions, universities and educational bodies that receive or use tissue are indirectly affected through the downstream authority and confidentiality rules.

Consent and revocation rights are the Act’s conceptual core. A living adult’s written consent to regenerative-tissue removal is effective once a s 9 certificate is given (s 12); non-regenerative consent requires a 24-hour delay (s 13). Child donors possess a statutory right to withdraw agreement at any time; continued objection after a s 11 certificate renders the authority ineffective (s 15(c)). Next of kin may delegate their functions in writing (s 5A); the principal care officer may delegate State-care functions (s 5B).

Duty to inquire is imposed on designated officers before any post-death authority (ss 23(3), 24(4), 28(3), 31A(3)). They must ascertain whether the deceased expressed an objection and whether any higher-order relative objects. Failure to inquire can constitute an offence (s 36(3)(a)), though the validity of the authority is preserved (s 27(2)).

Medical practitioners’ duties include explaining procedures (ss 9(b), 11(b)), certifying capacity and voluntariness, and refraining from acting on a certificate they know to be false or where revocation has occurred (s 15). Two independent practitioners must certify brain death where ventilation continues (s 26); neither may be involved in the transplant (s 26(1A)).

Donor and supplier duties under the blood provisions are stringent. Donors must not sign false certificates (s 20E, 50 penalty units or 12 months). Suppliers must ensure certificates are obtained, testing is performed to Ministerial standards, and contaminated products are not used once the risk becomes known (s 20F(4)–(5)).

Rights of the deceased are protected through the primacy given to prior expressed wishes. Any known objection defeats next-of-kin consent (ss 23(3)(a), 24(4)(a), 28(3)(a), 29(4)(a)). Part 4A requires that ante-mortem procedures not occur if the potential donor has previously objected (s 27C(2)(b)(iii)).

Confidentiality is a right enforceable by criminal sanction. Section 37 prohibits disclosure of identifying information about donors, recipients or persons the subject of consent, subject to consent, lawful excuse, research or court-order exceptions. The prohibition binds a wide class of persons connected with hospitals or blood services.

Dignity is expressly elevated in s 31D: “In the conduct of a post-mortem examination under an authority conferred by this Act, regard is to be had to the dignity of the deceased person.”

Most substantive offences carry a maximum of 40 penalty units or six months’ imprisonment, or both: unauthorised removal of tissue (s 36(1)), use of surgical or post-mortem tissue without authority (s 36(1A), (2A)), failure to pass on revocation information (s 16(3)–(5)), coronial non-compliance (s 25(1)), false certificates (s 36(3)(b)), and trading (s 32(1)). Supplying blood or blood products without exempt-supplier status attracts 100 penalty units (s 21(1)–(2)); directors are personally liable (s 21B). False donor statements carry 50 penalty units or 12 months (s 20E). Inspector-related offences (non-compliance, false answers, obstruction) are punishable by 10 penalty units or three months (s 33H).

Enforcement is primarily by the Health Secretary through appointed inspectors (s 33A). Powers include warrantless entry at reasonable times (s 33B(1)), inspection of tissue, records and equipment, sample taking, questioning, copying and seizure (s 33B(2)). Search warrants may be obtained on belief of contravention (s 33G). Seized items can be retained for proceedings or, if contaminated, destroyed (s 33J(7)). Disallowance applications lie to the District Court within 10 days (s 33I). Injunctions to restrain unauthorised supply businesses are available to the Health Secretary in the Supreme Court without undertakings as to damages (s 21C).

Proceedings are summary and heard in the Local Court (s 38). The Act contains evidentiary presumptions (s 21A) and positive defences (s 20F) that shift the burden to the defendant on the balance of probabilities.

The Act is not a code. Section 34(1) expressly preserves the operation of any other Act or law authorising tissue removal. It therefore sits alongside the Coroners Act 2009 (NSW) (coronial consent overrides in ss 25, 30, 31B), the Anatomy Act 1977 (NSW) (body bequests for anatomical examination), the Assisted Reproductive Technology Act 2007 (NSW) (gamete supply, s 34(1)(b4)), and the Health Records and Information Privacy Act 2002 (NSW) (which limits publication of identifiable research data, s 34(3)).

Heavy cross-referencing occurs with the Health Services Act 1997 (NSW) for the definitions of “public hospital”, “public health organisation” and “governing body” (s 4(1)). The Private Health Facilities Act 2007 (NSW) defines private facilities and their licensees. The Guardianship Act 1987 (NSW) supplies the “person responsible” concept for adults under guardianship (s 21Z) and interacts with Part 4A ante-mortem authorities (s 27F). The Children and Young Persons (Care and Protection) Act 1998 (NSW) determines when a child is “in the care of the State” (s 4(7)) and identifies the Minister or Secretary with parental responsibility.

The Therapeutic Goods Act 1989 (Cth) is incorporated by reference in the expanded exempt-supplier definition (s 4(1)(a1)–(a2)) for registered or exempt blood products. The Interpretation Act 1987 (NSW) supplies the de-facto-partner definition (note to s 4(1)) and general interpretation rules (s 4 note).

Liability shields in s 20F interact with the common law of negligence and contract. The Act’s confidentiality rule (s 37) operates in addition to, not in substitution for, equitable and statutory privacy obligations. Cost-recovery under s 37A is a statutory debt independent of any contractual arrangement between blood suppliers and health providers.

The most recent substantive amendment is the Human Tissue Amendment (Ante-mortem Procedures) Act 2024, which inserted Part 4A. The explanatory materials state the change was required to align New South Wales with national reform and with practices in other jurisdictions that permit limited ante-mortem interventions (e.g. heparin administration, blood sampling) to optimise organ viability once death is imminent. The new provisions require independent medical certification that the procedures will not hasten death or cause more than minimal harm (s 27C(3)(b)), reflecting concerns about the ethical boundary between end-of-life care and donation optimisation.

In 2012 the Human Tissue Legislation Amendment Act inserted s 27A (guidelines on recording reasons for not proceeding with donation despite consent) and amended the next-of-kin objection test in ss 23 and 24 to require regard to the “most recent views” of the deceased. The 2012 Act also expanded technician removal powers (s 27(1A)). These changes responded to stagnant donation rates and coronial and family objections that were not always aligned with the deceased’s wishes.

The 2008 Human Tissue Amendment (Children in Care of State) Act introduced ss 23A, 24A and 24B after public controversy concerning the removal of tissue from children who died in State care without adequate consultation. The amendments require the principal care officer to consult widely and obtain approvals before consenting, and prohibit non-transplant uses (s 34A).

The 2004 Health Legislation Amendment Act substituted Part 3, introduced the exempt-supplier regime in Part 3A, and created the infection-liability defences in s 20F. The changes were driven by the need to implement national blood-safety reforms after the HIV and hepatitis C contaminated-blood inquiries of the 1980s and 1990s, while protecting the voluntary donor base.

The 2003 Human Tissue and Anatomy Legislation Amendment Act was the largest single overhaul. It inserted Part 3C (surgical tissue), Division 2 of Part 5 (post-mortem tissue use), Part 7A (enforcement), updated next-of-kin definitions to include de-facto partners, and strengthened record-keeping and dignity requirements. The reforms responded to the 1990s inquiries into retained organs (Snowy Mountains, King Edward Memorial, Alder Hey) that revealed widespread non-consensual retention of tissue for research.

There has been no High Court or NSW Court of Appeal decision directly construing the Act’s core consent provisions. However, several controversies have shaped its development. The Royal Commission into the New South Wales Health System (2008) criticised fragmented donation coordination and recommended the “most recent views” test later enacted in 2012. Coroners have repeatedly expressed frustration at late notification of potential donors, leading to the guideline power in s 27A.

In the blood-supply context, the 1980s–1990s contaminated-blood litigation (largely settled before judgment) prompted the policy decision to grant broad defences in s 20F while preserving liability for knowing or reckless conduct. No reported decision has tested the s 20F(4) “all reasonably practicable steps” defence.

The ante-mortem amendments of 2024 were preceded by ethical debate within the Australian Organ and Tissue Donation and Transplantation Authority. Critics argued that any intervention on a dying patient solely to benefit a third party risks breaching the dead-donor rule. The legislation’s insistence on independent certification and the exclusion of normothermic regional perfusion reflect a legislative compromise.

Family objections after the deceased had registered consent on the Australian Organ Donor Register have been a persistent practical controversy. The 2012 amendments and s 27A guidelines were designed to address the “family override” problem without removing the statutory inquiry duty. No court has yet ruled on whether a designated officer’s “reasonable inquiries” must include checking the national register.

Most practitioners assume that a tick on the Australian Organ Donor Register constitutes sufficient authority under the Act. It does not. The Register is an administrative tool only; the Act still requires a written consent or next-of-kin authority plus a designated officer’s satisfaction after reasonable inquiries (s 23(1)). Hospitals have been criticised by coroners for treating the Register as automatic authorisation.

Another trap is the interaction between s 26 brain-death certification and transplant-team involvement. The two certifying practitioners must be independent of both the removal team and the recipient’s treating team (s 26(1A)). A common error is to involve the ICU consultant who will later assist with organ retrieval.

Section 15’s revocation rules are broader than many realise. Actual knowledge or “reasonable grounds for suspecting” revocation, a false certificate, or a child’s change of mind defeats the authority. The obligation to pass on revocation information (s 16(3)–(4)) carries personal criminal liability for nurses, attending doctors and designated officers alike.

For blood suppliers, the s 20F defence is lost the moment the supplier “becomes aware” that the product is or is likely to be contaminated, even if the product has already left the shelf. The “reasonably practicable steps” obligation is ongoing.

Part 3C is frequently overlooked. Tissue removed during routine surgery (e.g. appendices, tumours, placenta) cannot be used for research or teaching without an express authority under s 21X–21ZA. Many ethics committees still approve projects on the mistaken assumption that surgical waste is ownerless.

The 10-penalty-unit offence for next-of-kin who authorise use despite known objection (ss 21Y(2), 21ZA(2), 29(4)) is rarely prosecuted but creates real exposure for senior relatives who override a clearly expressed wish.

Finally, the definition of “child” (person under 18 and unmarried, s 4(1)) interacts awkwardly with the marriage-age reforms. A 17-year-old who is legally married is an adult for the purposes of the Act, altering the entire consent pathway.

Compliance begins with governance. Every public and private hospital and forensic institution must appoint an appropriate number of designated officers and, where relevant, designated specialists (s 5). Appointments should be documented by instrument in writing and refreshed periodically. A written protocol should set out the exact sequence of inquiries required by ss 23, 24, 28 and 31A, including mandatory checks of the Australian Organ Donor Register, medical records and discussion with all reasonably available relatives in the statutory hierarchy.

For living donation, use standardised consent forms that reproduce the exact wording of ss 7, 8 and 10. The certifying medical practitioner must be independent of the transplant team. For child donors, two certificates (or the dual s 11A certificate) must be completed before any removal. Retain all certificates for the period prescribed by regulation.

Blood-collection agencies must embed the s 20D certificate process into donor workflows. Electronic systems should flag any prior positive test for a prescribed contaminant and prevent repeat donation. Supplier contracts with hospitals should contain indemnity and audit clauses that mirror the s 20F defences.

Surgical teams must obtain specific s 21X consent before using excised tissue for non-therapeutic purposes. Pathology departments should maintain a register of retained tissue slides and blocks that fall within the s 34(1)(b1) quality-assurance exception; any other research use requires fresh authority.

Post-mortem and ante-mortem pathways require pre-established relationships with the coronial jurisdiction. Designated officers should have standing arrangements for after-hours coronial advice. For ante-mortem procedures, the independent practitioner’s certificate must be obtained before any intervention; the file note should expressly address each of the three negative criteria in s 27C(3)(b).

Record-keeping is mandatory. Regulations made under s 39(1) and clause 1 of Schedule 1 require detailed logs of every consent, authority, certificate, inquiry and decision not to proceed. Electronic systems must be auditable by inspectors.

Education is continuous. Annual training for ICU staff, theatre nurses, social workers and designated officers should cover the exact wording of the next-of-kin hierarchy, the revocation rules, and the dignity obligation in s 31D. Simulated family conversations have proved effective in reducing family overrides.

Finally, organisations should maintain a “tissue-use register” that tracks every sample from removal through to final disposition (transplant, research, disposal). This single source of truth satisfies inspector demands under s 33B and minimises the risk of inadvertent unauthorised use. Regular internal audits against the s 39 regulation standards and the Health Secretary’s guidelines under s 27A complete the compliance picture.